Position in MNKD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,109,813
-$2,514,727 QoQ
Shares Held
452,986
-29.1% QoQ
Ownership
0.147%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in MNKD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026AQR CAPITAL MANAGEMENT LLC holds $4,607,242,753 across 213 Biotechnology names. MNKD ranks #124 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,231,008 | $951,126,014 | |
| 2 | EXEL |
Exelixis, Inc.
|
13,095,741 | $561,676,326 | |
| 3 | INCY |
Incyte Corp
|
5,807,930 | $546,642,368 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
7,676,541 | $433,647,798 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
913,104 | $302,118,715 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,338,458 | $253,035,481 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,782,038 | $181,424,357 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
5,946,858 | $164,727,963 |
All Filings in MNKD
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,109,813 | 452,986 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $3,624,540 | 639,249 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $3,955,963 | 736,679 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $170,808 | 45,671 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $278,323 | 55,333 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $296,891 | 46,173 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $274,199 | 43,593 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $223,050 | 42,730 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $179,006 | 39,516 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $138,924 | 38,166 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $162,300 | 39,298 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $172,384 | 42,355 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $174,090 | 42,461 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $204,402 | 38,786 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $122,292 | 39,577 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $150,559 | 39,517 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $145,422 | 39,517 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $215,340 | 49,277 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $214,354 | 49,277 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $268,559 | 49,277 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $193,165 | 49,277 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $154,237 | 49,277 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $74,291 | 39,517 | Shares | Defined | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||